<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03873077</url>
  </required_header>
  <id_info>
    <org_study_id>MMS.2019.001</org_study_id>
    <nct_id>NCT03873077</nct_id>
  </id_info>
  <brief_title>Effect of LIA on Postoperative Pain Following ACL Reconstruction</brief_title>
  <official_title>Effect of Local Infiltration Analgesia on Postoperative Pain Following Anterior Cruciate Ligament Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Algemeen Ziekenhuis Maria Middelares</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Algemeen Ziekenhuis Maria Middelares</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An anterior cruciate ligament (ACL) rupture is one of the most common sport injuries, which
      typically develops after a sudden knee torsion. Arthroscopic repair of the ACL is often
      required as a complete ACL tear can cause instability of the knee joint.

      During arthroscopic reconstruction the lower leg is reattached to the upper leg using part of
      the hamstring tendon (mm. gracilis and mm. semitendinosus). Optimal postoperative analgesia
      is necessary to allow a quick recovery. Intravenous analgesia during surgery is often
      associated with a number of side effects such as nausea, vomiting and muscle weakness and
      does not anesthetize the donor site of the hamstring tendon graft. Local infiltration of
      ropivacaine and lidocaine in the knee joint and at the donor site can be a valuable asset to
      control the postoperative pain.

      This study evaluates the effect of local infiltration analgesia (LIA) on the postoperative
      pain in the first month after an ACL reconstruction. Half of participants will only receive
      intravenous analgesia during surgery, the other half will receive intravenous analgesia and a
      LIA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      2 x 20 patients which are planned for arthroscopic ACL reconstruction are randomised:
      standard-group and LIA-group.

      All patients receive standardised multimodal intravenous analgesia. After standardised
      induction of anesthesia, patient positioning and administration of basic analgetics
      (paracetamol, diclofenac, clonidine and morfine), patients in the LIA-group receive a local
      infiltration in the knee of 10 mL ropivacaine and 10 mL lidocaine.

      Visual Analogue Scores are assessed 15 minutes after awakening from surgery and on Day 1, 2,
      3, 7, 14, 21 and 28 after surgery. Postoperative analgesic consumption are registered in the
      first month after the surgery. The quality of recovery after anesthesia is assessed on Day 1
      by the postoperative quality of recovery score (QoR-15).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group A receives standard treatment (intravenous analgesia). Group B received intravenous analgesia and a LIA.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale for pain</measure>
    <time_frame>From moment of surgery until one month after surgery</time_frame>
    <description>Pain intensity using the VAS (where 0 = no pain and 100 = pain as bad as can be) 15 minutes after awakening and on Day 1, 2, 3, 7, 14, 21 and 28 after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative analgesia consumption</measure>
    <time_frame>From moment of surgery until one month after surgery</time_frame>
    <description>Dosing and frequency of analgesia consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General patient comfort</measure>
    <time_frame>From moment of surgery until one day after surgery</time_frame>
    <description>Quality of recovery score (QoR-15) on the first day after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nausea and vomiting</measure>
    <time_frame>From moment of surgery until hospital discharge (one day after surgery)</time_frame>
    <description>Incidence of postoperative nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PONV treatment</measure>
    <time_frame>From moment of surgery until hospital discharge (one day after surgery)</time_frame>
    <description>Number of pharmacological treatments for postoperative nausea and vomiting (PONV)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Anterior Cruciate Ligament Rupture</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>intravenous analgesia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient receives intravenous analgesia: paracetamol 30 mg/kg, diclofenac 75 mg, clonidine 1 Âµg/kg and morfine 0,05 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous analgesia + LIA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient receives intravenous analgesia and a local infiltration analgesia in the knee</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>local infiltration analgesia</intervention_name>
    <description>10 mL ropivacaine 7.5 mg/mL and 10 mL lidocaine 10 mg/mL</description>
    <arm_group_label>intravenous analgesia + LIA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective arthroscopic anterior cruciate ligament reconstruction

          -  adult

        Exclusion Criteria:

          -  unwilling or unable to grant written informed consent

          -  revisions

          -  contra-indication for ropivacaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain F Kalmar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maria Middelares Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alain F Kalmar, MD, PhD, MSc</last_name>
    <phone>+32 246 17 29</phone>
    <email>alainkalmar@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pieter Byn, MD, Msc</last_name>
    <email>pieterbyn@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>General Hospital Maria Middelares</name>
      <address>
        <city>Ghent</city>
        <state>Oost-Vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain F Kalmar</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.</citation>
    <PMID>23411725</PMID>
  </reference>
  <reference>
    <citation>Lefevre N, Klouche S, de Pamphilis O, Herman S, Gerometta A, Bohu Y. Peri-articular local infiltration analgesia versus femoral nerve block for postoperative pain control following anterior cruciate ligament reconstruction: Prospective, comparative, non-inferiority study. Orthop Traumatol Surg Res. 2016 Nov;102(7):873-877. doi: 10.1016/j.otsr.2016.07.011. Epub 2016 Oct 4.</citation>
    <PMID>27720193</PMID>
  </reference>
  <reference>
    <citation>Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop. 2008 Apr;79(2):174-83. doi: 10.1080/17453670710014950.</citation>
    <PMID>18484242</PMID>
  </reference>
  <reference>
    <citation>Kristensen PK, Pfeiffer-Jensen M, Storm JO, Thillemann TM. Local infiltration analgesia is comparable to femoral nerve block after anterior cruciate ligament reconstruction with hamstring tendon graft: a randomised controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):317-23. doi: 10.1007/s00167-013-2399-x. Epub 2013 Jan 23.</citation>
    <PMID>23338666</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2019</study_first_posted>
  <last_update_submitted>March 11, 2019</last_update_submitted>
  <last_update_submitted_qc>March 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Algemeen Ziekenhuis Maria Middelares</investigator_affiliation>
    <investigator_full_name>Dr. Alain Kalmar, MD, PhD</investigator_full_name>
    <investigator_title>Staff Anesthesist</investigator_title>
  </responsible_party>
  <keyword>local infiltration analgesia</keyword>
  <keyword>postoperative analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

